Category: Providers

Incyte Becomes 26th Drugmaker to Place Contract Pharmacy Restrictions

September 21, 2023 Rich Daly, Editor in Chief Views

Incyte will no longer allow 340B hospitals to have direct delivery of Opzelura products purchased at the 340B discount price to contract pharmacies.

Drug manufacturer Incyte Corp. this week announced it will become the 26th drug manufacturer to restrict access to 340B pricing when [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

One Quarter of HRSA Provider Audits Closed with No Adverse Findings

September 21, 2023 Rich Daly, Editor in Chief Views

Dept. of Health and Human Services sign and building

There were no adverse findings in nearly one quarter of provider audits conducted by HRSA, an agency within HHS.

Nearly one-quarter of the 200 provider audits planned for this year were closed by regulators with no adverse findings, they [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Providers Split on 340B Medicaid Provisions in Major House Healthcare Package

September 19, 2023 William Newton, Associate Editor/Senior Writer Views

Joe Dunn, senior vice president of public policy and research at NACHC, said his organization supported the Lower Costs, More Transparency Act.

Provider groups diverged over 340B Medicaid managed care provisions in a sweeping healthcare package on which the House of Representatives [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

AHF Files Appeal Over Its Claim That Apexus Did Not Obtain Sub-Ceiling Discounts

September 19, 2023 Rich Daly, Editor in Chief Views

AHF appealed a ruling to dismiss by U.S. District Judge Percy Anderson over AHF's claim that Apexus did not obtain sub-ceiling discounts..

The AIDS Healthcare Foundation (AHF) recently filed an appeal to an April district court dismissal of its case against Apexus, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Health Center Challenging 340B Patient Definition Responds to HRSA’s and Drug Companies’ Court Arguments

September 19, 2023 Tom Mirga, Editor at Large Views

Genesis Health Care successfully challenged HRSA's 340B patient definition in the U.S. District Court for the District of South Carolina.

There is no evidence to support federal allegations that a South Carolina community health center illegally diverts 340B-purchased drugs to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Novo Nordisk Providing 340B Refunds on Blockbuster Drug Ozempic

September 19, 2023 Tom Mirga, Editor at Large Views

Drugmaker Novo Nordisk is issuing 340B refunds for certain purchases of its blockbuster diabetes medication Ozempic.

Novo Nordisk will issue refunds to 340B covered entities for some purchases this year of its blockbuster injectable diabetes medication [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

AHIP Objects to Hospital Efforts to Target Medicare Advantage 340B ‘Windfall’

September 19, 2023 Rich Daly, Editor in Chief Views

Matthew Eyles, president and CEO of AHIP, objected to hospital-sought rules that target the Medicaid Advantage 340B "windfall."

The largest health insurer advocacy organization urged federal regulators to reject hospital-sought rules to limit the ability of Medicare Advantage [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Health Centers Appeal Loss in California Medicaid Lawsuit

September 14, 2023 Rich Daly, Editor in Chief Views

Michelle Baass, director of the California Department of Health Care Services, was the defendant in a California Medicaid lawsuit by health centers.

California health centers that participate in the 340B program recently appealed a federal district judge’s dismissal of a suit to reverse [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Driving Anti-Competitive Health System Tactics, Says Lawsuit

September 14, 2023 Rich Daly, Editor in Chief Views

An independent cancer care practice filed a federal lawsuit against Jefferson Health related to the 340B program.

An independent cancer care practice is suing a Philadelphia health system in federal court over a range of alleged anti-competitive [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Two More Drugmakers Owe 340B Provider Repayments, HRSA Audits Find

September 14, 2023 Rich Daly, Editor in Chief Views

The Health Resources and Services Administration announced that the Office of Pharmacy Affairs will hold a June 11 webinar on the ADR final rule.

Two drugmakers owe repayment to 340B covered entities, according to final audits posted this week by federal officials. American Health [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live